These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 21904029)
1. Inhibitor-bound structures of human pyruvate dehydrogenase kinase 4. Kukimoto-Niino M; Tokmakov A; Terada T; Ohbayashi N; Fujimoto T; Gomi S; Shiromizu I; Kawamoto M; Matsusue T; Shirouzu M; Yokoyama S Acta Crystallogr D Biol Crystallogr; 2011 Sep; 67(Pt 9):763-73. PubMed ID: 21904029 [TBL] [Abstract][Full Text] [Related]
2. Pyruvate dehydrogenase kinase-4 structures reveal a metastable open conformation fostering robust core-free basal activity. Wynn RM; Kato M; Chuang JL; Tso SC; Li J; Chuang DT J Biol Chem; 2008 Sep; 283(37):25305-25315. PubMed ID: 18658136 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia. Sugden MC; Holness MJ Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):151-65. PubMed ID: 12476789 [TBL] [Abstract][Full Text] [Related]
4. Pyruvate dehydrogenase kinase isoform 2 activity limited and further inhibited by slowing down the rate of dissociation of ADP. Bao H; Kasten SA; Yan X; Roche TE Biochemistry; 2004 Oct; 43(42):13432-41. PubMed ID: 15491150 [TBL] [Abstract][Full Text] [Related]
5. Crystal structures of ADP and AMPPNP-bound propionate kinase (TdcD) from Salmonella typhimurium: comparison with members of acetate and sugar kinase/heat shock cognate 70/actin superfamily. Simanshu DK; Savithri HS; Murthy MR J Mol Biol; 2005 Sep; 352(4):876-92. PubMed ID: 16139298 [TBL] [Abstract][Full Text] [Related]
6. Crystal structure of pyruvate dehydrogenase kinase 3 bound to lipoyl domain 2 of human pyruvate dehydrogenase complex. Kato M; Chuang JL; Tso SC; Wynn RM; Chuang DT EMBO J; 2005 May; 24(10):1763-74. PubMed ID: 15861126 [TBL] [Abstract][Full Text] [Related]
7. Regulatory roles of the N-terminal domain based on crystal structures of human pyruvate dehydrogenase kinase 2 containing physiological and synthetic ligands. Knoechel TR; Tucker AD; Robinson CM; Phillips C; Taylor W; Bungay PJ; Kasten SA; Roche TE; Brown DG Biochemistry; 2006 Jan; 45(2):402-15. PubMed ID: 16401071 [TBL] [Abstract][Full Text] [Related]
8. Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding. Sugden MC; Bulmer K; Gibbons GF; Holness MJ Arch Biochem Biophys; 2001 Nov; 395(2):246-52. PubMed ID: 11697863 [TBL] [Abstract][Full Text] [Related]
9. Pyruvate dehydrogenase kinase isoform 2 activity stimulated by speeding up the rate of dissociation of ADP. Bao H; Kasten SA; Yan X; Hiromasa Y; Roche TE Biochemistry; 2004 Oct; 43(42):13442-51. PubMed ID: 15491151 [TBL] [Abstract][Full Text] [Related]
10. Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone. Holness MJ; Bulmer K; Smith ND; Sugden MC Biochem J; 2003 Feb; 369(Pt 3):687-95. PubMed ID: 12435272 [TBL] [Abstract][Full Text] [Related]
16. The closed conformation of a highly flexible protein: the structure of E. coli adenylate kinase with bound AMP and AMPPNP. Berry MB; Meador B; Bilderback T; Liang P; Glaser M; Phillips GN Proteins; 1994 Jul; 19(3):183-98. PubMed ID: 7937733 [TBL] [Abstract][Full Text] [Related]
17. The conformations of a substrate and a product bound to the active site of S-adenosylmethionine synthetase. Schalk-Hihi C; Markham GD Biochemistry; 1999 Feb; 38(8):2542-50. PubMed ID: 10029549 [TBL] [Abstract][Full Text] [Related]
18. Structural basis for the inhibition of PDK2 by novel ATP- and lipoyl-binding site targeting compounds. Kang J; Pagire HS; Kang D; Song YH; Lee IK; Lee KT; Park CJ; Ahn JH; Kim J Biochem Biophys Res Commun; 2020 Jun; 527(3):778-784. PubMed ID: 32444142 [TBL] [Abstract][Full Text] [Related]
19. Crystal structures of MEK1 binary and ternary complexes with nucleotides and inhibitors. Fischmann TO; Smith CK; Mayhood TW; Myers JE; Reichert P; Mannarino A; Carr D; Zhu H; Wong J; Yang RS; Le HV; Madison VS Biochemistry; 2009 Mar; 48(12):2661-74. PubMed ID: 19161339 [TBL] [Abstract][Full Text] [Related]
20. The carboxy-terminal tail of pyruvate dehydrogenase kinase 2 is required for the kinase activity. Klyuyeva A; Tuganova A; Popov KM Biochemistry; 2005 Oct; 44(41):13573-82. PubMed ID: 16216081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]